The participant, FK, was a 56-year old, right-handed, Persian speaking housewife with three years of formal education. She had been experiencing a decline in the language performance over a period of approximately one year prior to this study and complained of increasing problems in word finding and names remembering of familiar people. FK was examined and diagnosed at the specialized memory clinic of Rozbeh hospital (Tehran University of Medical Sciences). The criteria for selection of the participant include having early to moderate language difficulties associated with a working diagnosis of PPA which were determined by multidisciplinary team including an expert cognitive neurologist, a neuropsychologist, and speech-language pathologists, based on Mesulam’s cores that are as follows: 1) predominance of language impairments over other clinical features (including word-finding deficits, paraphasia, halting speech, grammatical and/or phonological deficits in speech); 2) prominence of aphasia during the initial phase of the disorder (relative absence of memory, visuospatial, behavioral and affective deficits and disorders at the onset); 3) embodying a neurodegenerative nature, hence being progressive such that the observed deficits cannot be attributed to any other pathologies (
9,
10), speak conversational Persian, word finding difficulties and having adequate hearing and vision. The exclusion criteria included an inability to give informed consent and a history of other neurological diseases (e.g., stroke, head injury, Parkinson’s disease), and severe psychiatric and cognitive disorders. Demographic information of FK is described in
Table 1. FK was diagnosed with a non-fluent variant of PPA associated with apraxia of speech. Her language was effortful with halting speech, impaired word retrieval, and spared comprehension. In addition, there were many phonological errors in her repetition and her spontaneous speech was described as poor and interrupted with word retrieval difficulties. A working diagnosis of the PPA sub-type was agreed with the consensus criteria suggested by Gorno-Tempini et al. (
9), and finally, the diagnosis was confirmed by structural brain magnetic resonance imaging (MRI) in which frontal and left perisylvian atrophy was confirmed.
This study was approved by the ethics committee of Tehran University of Medical Sciences (approval number: IR.TUMS.REC.1394.2149) and written informed consent was obtained from both the participant and her husband prior to the inclusion in the study.